Single and Multiple Ascending Doses of MEDI6570 in Participants with Type 2 Diabetes Mellitus

Trial Identifier: D4920C00001
Sponsor: MedImmune, LLC
NCTID:: NCT03654313
Start Date: September 2018
Primary Completion Date: July 2020
Study Completion Date: July 2020
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Spanish Translation

Trial Locations

Country Location
US, AL Anniston, AL, US, 36207
US, FL Jacksonville, FL, US, 32216
US, FL Port Orange, FL, US, 32127
US, FL South Miami, FL, US, 33143
US, HI Honolulu, HI, US, 96814
US, NC High Point, NC, US, 27265
US, OH Cincinnati, OH, US, 45227
US, TN Knoxville, TN, US, 37920
US, TX San Antonio, TX, US, 78229